Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway

被引:76
作者
Kanai, M
Konda, Y
Nakajaima, T
Izumi, Y
Kanda, N
Nanakin, A
Kubohara, Y
Chiba, T
机构
[1] Kyoto Univ, Grad Sch Med, Div Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan
[2] Gunma Univ, Inst Mol & Cellular Regulat, Dept Mol Physiol, Maebashi, Gumma 3718512, Japan
关键词
DIF-1; STAT3; ERK; cell growth; gastric cancer;
D O I
10.1038/sj.onc.1206109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Differentiation-inducing factor-1 (DIF-1) is a chlorinated hexaphenone isolated from Dictyostelium. DIF-1 exhibits antitumor activity in several types of mammalian tumor cells, although the underlying mechanisms remain unknown. On the other hand, recent studies indicate that constitutively activated STAT3 acts as an oncogene and could be a target for antitumor drug. In the present study, we examined the effects of DIF-1 on proliferation of gastric cancer cell lines as well as on its signal transduction pathways, focusing mainly on STAT proteins. DIF-1 inhibited proliferation of gastric cancer cells. Western blot analysis and electrophoretic mobility shift assay showed that DIF-1 inhibited STAT3 activity in an MEK-ERK-dependent manner in gastric cancer cell lines, AGS and MKN28. Moreover, blockade of STAT3 activity by ectopic expression of dominant-negative STAT3 or the Janus kinase inhibitor, tyrphostin AG490, inhibited cell growth of AGS cells. These results suggest that STAT3 activity plays an important role for cell growth in AGS cells, and raises the possibility that inhibition of STAT3 activity is one of the mechanisms responsible for the antitumor effect of DIF-1 in these cells.
引用
收藏
页码:548 / 554
页数:7
相关论文
共 31 条
[1]   DIF-1, MORPHOGEN OF DICTYOSTELIUM-DISCOIDEUM, INDUCES THE ERYTHROID-DIFFERENTIATION IN MURINE AND HUMAN LEUKEMIA-CELLS [J].
ASAHI, KI ;
SAKURAI, A ;
TAKAHASHI, N ;
KUBOHARA, Y ;
OKAMOTO, K ;
TANAKA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 208 (03) :1036-1039
[2]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[3]   Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells [J].
Burke, WM ;
Jin, XH ;
Lin, HJ ;
Huang, M ;
Liu, R ;
Reynolds, RK ;
Lin, JY .
ONCOGENE, 2001, 20 (55) :7925-7934
[4]   STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation [J].
Chung, JK ;
Uchida, E ;
Grammer, TC ;
Blenis, J .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6508-6516
[5]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[6]   Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells [J].
Garcia, R ;
Bowman, TL ;
Niu, GL ;
Yu, H ;
Minton, S ;
Muro-Cacho, CA ;
Cox, CE ;
Falcone, R ;
Fairclough, R ;
Parsons, S ;
Laudano, A ;
Gazit, A ;
Levitzki, A ;
Kraker, A ;
Jove, R .
ONCOGENE, 2001, 20 (20) :2499-2513
[7]  
Gollob JA, 1999, J IMMUNOL, V162, P4472
[8]  
GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159
[9]   Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro [J].
Grandis, JR ;
Drenning, SD ;
Chakraborty, A ;
Zhou, MY ;
Zeng, Q ;
Tweardy, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1385-1392
[10]   STATs: Signal transducers and activators of transcription [J].
Ihle, JN .
CELL, 1996, 84 (03) :331-334